During the past decade, Jackson Oncology Associates PLLC conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 19 clinical trials were completed, i.e. on average, 105.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 10 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jackson Oncology Associates PLLC" #1 sponsor was "SCRI Development Innovations, LLC" with 6 trials, followed by "Bristol-Myers Squibb" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Novartis Pharmaceuticals" with 4 trials sponsored and "Eli Lilly and Company" with 4 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jackson Oncology Associates PLLC" #1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Jackson Oncology Associates PLLC" are "Breast Cancer" (10 trials), "Non-Small Cell Lung Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Multiple Myeloma" (3 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Jackson Oncology Associates PLLC" in a lesser frequency.

Most popular intervention types in "Jackson Oncology Associates PLLC" are "Drug" (42 trials), "Other" (5 trials), "Biological" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Paclitaxel" (5 trials), "Carboplatin" (4 trials), "Docetaxel" (4 trials) and "Letrozole" (4 trials). Other intervention names were less common.

The vast majority of trials in "Jackson Oncology Associates PLLC" are 40 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Jackson Oncology Associates PLLC". undefined are not yet recruiting, 2 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Jackson Oncology Associates PLLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Jackson Oncology Associates PLLC, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".